IL33 and Increased total eosinophil count: I.n. IL-33 injections induced mild eosinophilia in the CD127 cKO mouse liver, likely due to the residual ILC2s, while there was no increase in other myeloid populations (Figure 5F), indicating that ILC2s are responsible for the type 2 skewing seen in the liver after i.n. IL-33 treatment.